secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2022-11-30T23:59:59+00:00
Accession:  0001193125-22-295368
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences updates corporate presentation; no new material information disclosed
--------------------------------------------------------------------------------

- Aura Biosciences posted an updated corporate presentation for investor and analyst meetings as of November 30, 2022.
- The presentation update does not include any new financial results, clinical trial data, or material business changes.
- No specific numbers, dates, or events were provided in the filing text to analyze.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312522295368/0001193125-22-295368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312522295368/d378294d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-295368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer